Department of Clinical Laboratory, Peking University Shenzhen Hospital, Guangdong, China.
Biochem Biophys Res Commun. 2012 Mar 23;419(4):621-6. doi: 10.1016/j.bbrc.2012.02.060. Epub 2012 Feb 17.
MicroRNAs (miRNAs) have emerged as powerful regulators of multiple processes linked to human cancer, including cell apoptosis, proliferation and migration, suggesting that the regulation of miRNA function could play a critical role in cancer progression. Recent studies have found that human serum/plasma contains stably expressed miRNAs. If they prove indicative of disease states, miRNAs measured from peripheral blood samples may be a source for routine clinical detection of cancer. Our studies showed that both miR-508-3p and miR-509-3p were down-regulated in renal cancer tissues. The level of miR-508-3p but not miR-509-3p in renal cell carcinoma (RCC) patient plasma demonstrated significant differences from that in control plasma. In addition, the overexpression of miR-508-3p and miR-509-3p suppressed the proliferation of RCC cells (786-0), induced cell apoptosis and inhibited cell migration in vitro. Our data demonstrated that miR-508-3p and miR-509-3p played an important role as tumor suppressor genes during tumor formation and that they may serve as novel diagnostic markers for RCC.
微小 RNA(miRNAs)已成为与人类癌症相关的多种过程的强大调控因子,包括细胞凋亡、增殖和迁移,这表明 miRNA 功能的调节可能在癌症进展中起关键作用。最近的研究发现,人类血清/血浆中含有稳定表达的 miRNAs。如果它们证明与疾病状态有关,那么从外周血样本中测量的 miRNAs 可能是癌症常规临床检测的一个来源。我们的研究表明,miR-508-3p 和 miR-509-3p 在肾癌组织中均下调。与对照血浆相比,肾细胞癌(RCC)患者血浆中 miR-508-3p 的水平而非 miR-509-3p 的水平表现出显著差异。此外,miR-508-3p 和 miR-509-3p 的过表达抑制了 RCC 细胞(786-0)的增殖,诱导细胞凋亡并抑制细胞迁移。我们的数据表明,miR-508-3p 和 miR-509-3p 在肿瘤形成过程中作为肿瘤抑制基因发挥重要作用,并且它们可能作为 RCC 的新型诊断标志物。